Author

D. Dearnaley

Observed name: D P DEARNALEY

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Royal Marsden Hospital

Observed institutions: St George's Hospital, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Cancer Research UK, Royal Marsden Hospital

OpenAlex ID: A5069002157

Dynamic contrast-enhanced MRI for prostate cancer localization

2009 · A S N JACKSON, S A REINSBERG, et al. · British Journal of Radiology · 102

Cardiovascular Disease as a Long Term Complication of Treatment for Testicular Cancer

2002 · R. A. Huddart, A. Norman, et al. · Springer eBooks · 37

Impact of Node Status and Radiotherapy on Failure-Free Survival in Patients with Newly Diagnosed Non-Metastatic Prostate Cancer: Data from >690 Patients in the Control Arm of the Stampede Trial

2014 · N. James, M. Spears, et al. · Annals of Oncology · 12

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Post-Operative Prostate Cancer

2020 · W.A. Hall, E.S. Paulson, et al. · International Journal of Radiation Oncology*Biology*Physics · 11

Sequencing of Androgen Deprivation Therapy of Short Duration with Radiotherapy for Non-Metastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials

2022 · T.M. Ma, Y. Sun, et al. · International Journal of Radiation Oncology*Biology*Physics · 5

Natural History after Likely Cure vs. Recurrence vs. after ProsTate RadiOtheRapy (RAPTOR): A Pooled Analysis of More than 13000 Patients from 21 Randomized Controlled Trials

2024 · S. Roy, T. Romero, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

The Interplay between Acute and Late Toxicity among Patients Receiving Prostate Radiotherapy: A Pooled Analysis of 7 Randomized Trials

2024 · J. Nikitas, P. Jamshidian, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

Challenges and Solutions during the COVID Pandemic for Patient Retention and Physician Engagement in the Phase 3 ATLAS Study of Apalutamide Added to Androgen Deprivation Therapy (ADT) in High-Risk Localized or Locally Advanced Prostate Cancer (HRLPC)

2022 · H.M. Sandler, N. Shore, et al. · International Journal of Radiation Oncology*Biology*Physics

1375P Intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC)

2022 · S. Halabi, A. Roy, et al. · Annals of Oncology

Works count: 9

Citation count: 169

H-index: 5

I10-index: 4